Capital Advisors, Ltd. LLC Amarin Corp Plcuk Transaction History

Capital Advisors, Ltd. LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$1.12 - $1.49 $1,680 - $2,235	-1,500 Reduced 7.59%	18,259 $22,000
Q1 2023 May 03, 2023	BUY	$1.19 - $2.19 $1,785 - $3,285	1,500 Added 8.22%	19,759 $30,000
Q3 2022 Nov 09, 2022	BUY	$1.09 - $1.67 $309 - $474	284 Added 1.58%	18,259 $20,000
Q4 2021 Feb 08, 2022	SELL	$3.24 - $5.18 $136,112 - $217,611	-42,010 Reduced 70.03%	17,975 $61,000
Q1 2021 May 13, 2021	BUY	$5.03 - $8.8 $90,414 - $158,180	17,975 Added 42.79%	59,985 $373,000
Q4 2020 Feb 10, 2021	SELL	$4.04 - $5.31 $107,868 - $141,777	-26,700 Reduced 38.86%	42,010 $205,000
Q4 2019 Feb 03, 2020	BUY	$13.94 - $24.12 $487,426 - $843,379	34,966 Added 103.62%	68,710 $1.47 Million
Q3 2019 Oct 23, 2019	BUY	$13.89 - $23.16 $468,704 - $781,511	33,744 New	33,744 $512,000
Q4 2018 Jan 29, 2019	SELL	$12.41 - $22.98 $67,026 - $124,114	-5,401 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$2.45 - $16.27 $13,232 - $87,874	5,401 New	5,401 $88,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.